Theralase Technologies (CVE:TLT) Trading 25.6% Higher – Here’s What Happened
by Mitch Edgeman · The Markets DailyTheralase Technologies Inc. (CVE:TLT – Get Free Report)’s share price was up 25.6% during mid-day trading on Friday . The company traded as high as C$0.27 and last traded at C$0.25. Approximately 1,188,265 shares changed hands during mid-day trading, an increase of 196% from the average daily volume of 401,785 shares. The stock had previously closed at C$0.20.
Theralase Technologies Stock Performance
The company has a current ratio of 1.91, a quick ratio of 3.40 and a debt-to-equity ratio of 14.85. The firm has a market capitalization of C$62.98 million, a P/E ratio of -13.61 and a beta of -0.35. The business’s 50 day simple moving average is C$0.17 and its two-hundred day simple moving average is C$0.19.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.